Zhang, Ran http://orcid.org/0000-0003-3376-6945
Fang, Jingqi http://orcid.org/0000-0002-5733-4373
Xie, Xueshu
Carrico, Chris
Meyer, Jesse G.
Wei, Lei
Bons, Joanna http://orcid.org/0000-0002-1110-4193
Rose, Jacob
Riley, Rebeccah http://orcid.org/0000-0002-5870-6837
Kwok, Ryan http://orcid.org/0000-0002-1850-6611
Ashok Kumaar, Prasanna Vadhana
Zhang, Yini http://orcid.org/0000-0002-8345-9997
He, Wenjuan
Nishida, Yuya
Liu, Xiaojing
Locasale, Jason W. http://orcid.org/0000-0002-7766-3502
Schilling, Birgit http://orcid.org/0000-0001-9907-2749
Verdin, Eric http://orcid.org/0000-0003-3703-3183
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R24DK085610, R24DK085610)
Glenn Foundation for Medical Research
National Natural Science Foundation of China (82301607)
U.S. Department of Health & Human Services | National Institutes of Health (T32GM8806, T32AG000266, U01AG060906, 1S10OD016281)
Larry L. Hillblom Foundation
Article History
Received: 5 July 2022
Accepted: 6 February 2024
First Online: 6 March 2024
Competing interests
: E.V. is a scientific co-founder of Napa Therapeutics and serves on the scientific advisory board of Seneque. E.V. receives research support from BaReCia. The remaining authors declare no competing interests.